SCHEMBL31691426

SCHEMBL31691426

COC(=O)c1ccc(Cc2ccccn2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.45
▸ PKM P14618 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ MAPT P10636 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ ALDH1A1 P00352 3/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ METAP2 P50579 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ RGS12 O14924 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31691389 0.86 KMT2A (0.47) ALOX15HTTKDM4EPKMMEN1
SCHEMBL31691416 0.85 KDM4E (0.45) KDM4EKMT2AMAPTPOLBNPC1
SCHEMBL25721981 0.81 TDP1 (0.52) ALOX15HTTKDM4EMEN1KMT2A
SCHEMBL28853596 0.81 EGFR (0.52) ALOX15HTTKDM4EPKMMEN1
SCHEMBL7834117 0.79 PKM (0.60) ALOX15HTTKDM4EPKMMEN1
SCHEMBL4313332 0.77 KMT2A (0.46) ALOX15HTTKDM4EPKMMEN1
SCHEMBL31691397 0.76 MRGPRX4 (0.43) ALOX15KDM4EPKMMEN1KMT2A
SCHEMBL19474955 0.76 ALDH1A1 (0.56) ALOX15KDM4EPKMMEN1KMT2A
SCHEMBL8890306 0.76 L3MBTL1 (0.50) ALOX15HTTKDM4EPKMMEN1
SCHEMBL14175211 0.75 TDP1 (0.52) ALOX15HTTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304535-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304535-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT2A ALOX15 3461/4885HTT 75/4885KDM4E 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback